🇺🇸 Nebilet in United States
729 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 729
Most-reported reactions
- Dyspnoea — 106 reports (14.54%)
- Fatigue — 77 reports (10.56%)
- Hypertension — 75 reports (10.29%)
- Diarrhoea — 74 reports (10.15%)
- Nausea — 73 reports (10.01%)
- Asthenia — 70 reports (9.6%)
- Pneumonia — 70 reports (9.6%)
- Dizziness — 63 reports (8.64%)
- Drug Ineffective — 62 reports (8.5%)
- Weight Decreased — 59 reports (8.09%)
Other Other approved in United States
Frequently asked questions
Is Nebilet approved in United States?
Nebilet does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Nebilet in United States?
Berlin-Chemie Menarini is the originator. The local marketing authorisation holder may differ — check the official source linked above.